CD34 and schwannoma: Our findings indicate that CD34+ cells exhibit significantly higher reprogramming efficiencies (1.199% ± 0.529), compared to fibroblasts (0.040% ± 0.103), PBMCs (0.015% ± 0.013), and schwannoma cells (0.121% ± 0.158).